In This Article:
As global markets react to the recent U.S. election results and economic policy shifts, major indices like the S&P 500 have reached record highs, fueled by investor optimism around potential growth and tax reforms. Amidst these developments, identifying stocks that may be undervalued can present intriguing opportunities for investors seeking to capitalize on discrepancies between market price and intrinsic value.
Top 10 Undervalued Stocks Based On Cash Flows
Name | Current Price | Fair Value (Est) | Discount (Est) |
goeasy (TSX:GSY) | CA$178.25 | CA$354.07 | 49.7% |
KMC (Kuei Meng) International (TWSE:5306) | NT$125.00 | NT$248.24 | 49.6% |
Aidma Holdings (TSE:7373) | ¥1698.00 | ¥3388.64 | 49.9% |
Adventure (TSE:6030) | ¥3590.00 | ¥7109.49 | 49.5% |
North Electro-OpticLtd (SHSE:600184) | CN¥11.35 | CN¥22.56 | 49.7% |
Laboratorio Reig Jofre (BME:RJF) | €2.87 | €5.74 | 50% |
Medios (XTRA:ILM1) | €14.76 | €29.48 | 49.9% |
BuySell TechnologiesLtd (TSE:7685) | ¥3925.00 | ¥7814.84 | 49.8% |
Delixi New Energy Technology (SHSE:603032) | CN¥17.95 | CN¥35.78 | 49.8% |
Cellnex Telecom (BME:CLNX) | €32.47 | €64.68 | 49.8% |
Let's dive into some prime choices out of the screener.
Revenio Group Oyj
Overview: Revenio Group Oyj specializes in ophthalmological devices and software for diagnosing glaucoma, macular degeneration, and diabetic retinopathy across Finland, Europe, North America, and internationally, with a market cap of €776.60 million.
Operations: Revenue from the Health Tech segment, which focuses on ophthalmological devices and software solutions for diagnosing eye conditions, amounts to €102.49 million.
Estimated Discount To Fair Value: 23.4%
Revenio Group Oyj is trading at €29.2, which is 23.4% below its estimated fair value of €38.14, indicating potential undervaluation based on cash flows. Despite a slight decline in quarterly net income to €4.2 million from €4.5 million the previous year, revenue increased to €23.9 million from €22 million year-over-year for Q3 2024, with annual earnings growth forecasted at 19.1%, outpacing the Finnish market's growth rate of 14.3%.
National Industrialization
Overview: National Industrialization Company engages in the petrochemicals, chemicals, plastics, engineering, and metals sectors globally with a market cap of SAR7.25 billion.
Operations: The company's revenue is primarily derived from its petrochemical segment at SAR1.95 billion, followed by the downstream & others segment at SAR1.37 billion, and the chemicals segment contributing SAR433.69 million.